TB infection and active TB are different subjects: Dr Suryakant

Lucknow: These are historic times because the President of the country Droupadi Murmu has inaugurated the “Pradhan Mantri TB Free India Campaign”, whose aim is to make TB Free India Campaign a mass movement. With these words Dr. Suryakant started the CME organized on TB.

The Continuing Medical Education Program on “TB Preventive Therapy”  was held in collaboration with Joint Effort for Elimination of Tuberculosis (jeet project) 2.0 project of Center for Health Research and Innovation (CHRI) under the aegis of Health Department under National Tuberculosis Eradication Program (NTEP).

Dr. Suryakant, chairman of the Uttar Pradesh State Task Force, National Tuberculosis Eradication Program and chairman of the Department of Respiratory Medicine, King George’s Medical University (KGMU), said that 26% of the world’s tuberculosis patients, 31% multi Drug resistant (MDR) TB and 38% of tuberculosis deaths occur in India. When a TB infected person coughs, 3500 TB bacteria are released from his mouth, whereas only one TB bacteria is enough to cause TB infection and active TB disease.

He told that having TB infection is a different topic and having active TB is a different topic. The bacteria are in a dormant state inside the body of a TB infected person and they do not have any symptoms of TB. Symptoms of TB in a patient with active TB include cough, blood in the cough, fever, stunted growth, lumps in the throat, etc. People who are malnourished or who smoke or drink, take drugs, who have HIV or diabetes, or have a chronic lung, heart or liver disease, are at higher risk of developing TB after a TB infection.

In the workshop, Dr. Richa Mishra of SGPGI informed that isoniazid preventive therapy (IPT) program is being run under NTEP to prevent tuberculosis infection. Till now, children up to the age of five were treated under this, but now this therapy will also be given to the family members of a person infected with tuberculosis. Under this, the family members of a TB infected patient, whether it is a child or an adult, are given anti-tuberculosis drugs for six months according to the age.

World Health Organization (WHO) State Consultant Dr Srishti Dixit said that infected family members are tested for TB and if they are not infected, they are given IPT. Under this, a tablet of INH (Isonicotinic Acid Hydrazide) is given. Family members are screened and treated on the basis of case history and contact tracing. Children below the age of 12 years do not produce mucus, so TB is diagnosed only on the basis of a sample from the stomach (gastric lavage) according to the case history and contact tracing of the child.

State Lead of Jeet Project, Dr Deepak told about the prevention of tuberculosis and Jeet Project. At the end of the program, the officiating District Tuberculosis Officer Dr RV Singh thanked everyone.

On this occasion, Dr. Prerna Kapoor, Senior Pediatrician and Nodal Officer of Tuberculosis, SGPGI, Dr. Zia Hashmi, Dr. Ajay Kumar Verma of Department of Respiratory Medicine, King George’s Medical University and other doctors, Lohia Hospital. Dr. Manish Kumar Singh from Dr. Shyama Prasad Mukherjee Hospital, Dr. D.K.Verma from Balrampur Hospital, Dr. Anand Gupta from Balrampur Hospital, Chief Medical Superintendent of District Hospitals, Medical Superintendent of Community Health Centers, NTEP. District Program Coordinator Dilshad Hussain, Senior Treatment Supervisor Abhay Chandra Mitra, Public Private Mix Manager Coordinator Ramji Verma, Soumitra Mitra, Former District Tuberculosis Officer Dr. Sushil Chaturvedi, Dr. B.K.Singh, Dr. Anshumali Srivastava of Prasad Medical College, Jeet Project Key District Lead, Anjul Sachan and the entire team of Jeet Project were present.

नोट: अगर आपको यह खबर पसंद आई तो इसे शेयर करना न भूलें, देश-विदेश से जुड़ी ताजा अपडेट पाने के लिए कृपया The Lucknow Tribune के  Facebook  पेज को Like व Twitter पर Follow करना न भूलें... ------------------------- ------------------------------------------------------ -------------------------------------------------------- ------------------------------------------------------------------- --------------------------------------------- --------------------------------------------------------------- --------------------------------------------------------- --------------------------------------------------------------------------   ----------------------------------------------------------- -------------------------------------------------- -----------------------------------------------------------------------------------------
----------- -------------------------------------------------------------------------------------------------------------------------------------------------
E-Paper